| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.63 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |